Trial Profile
Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2013
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 06 Mar 2012 New trial record